- Home
- » Tags
- » Efonidipine
Top View
- Calcium Channel Ca2+ Channels;Ca Channels
- Calcium Channel Ca2+ Channels; Ca Channels
- Qualitative/Quantitative Analysis and the Pharmacokinetic
- FDA-Approved Drug Library Mini (96-Well)
- Medication-Related Inpatient Falls: a Critical Review
- Marrakesh Agreement Establishing the World Trade Organization
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- A A-1048400, 41–42 Absence Epilepsy Definition, 95 Genetics Of, 101–103 Low-Voltage Threshold Antiseizure Drugs, 101 Cacna1a
- JSH 2004) 4Ii
- A Comparative Clinical Trial of Efonidipine and Amlodipine in Management of Stage-I Hypertension: a Randomized, Double-Blind Study in Indian Population
- What Kinds of Patients Requires Prophylactic Therapy?
- Wo 2007/044693 A2
- II. Molecular Docking, Spectral Data-Activity Relationship
- 210311 Wild Guided Report.Indd
- Table S1. Full Ksrepo Results for GSE58477 and GSE63409
- Harmonized Tariff Schedule of the United States (2006) (Rev
- A Review on Properties, Application, and Analytical Methods of an Antihypertensive Drug Efonidipine Grishma H Patel1, Shreya D Adeshra2, Dhananjay B Meshram3
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Efonidipine, a Calcium Channel Blocker, Alleviates Renal Injury Induced by Nitric Oxide Synthase Inhibition in Spontaneously Hypertensive Rats
- Pharmaceutical Appendix to the Harmonized Tariff Schedule
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Are Vasopressors Useful in Toxin-Induced Cardiogenic Shock?
- Pharmaceutical Appendix to the Tariff Schedule 2
- Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- An Application to Include Blood Pressure Lowering Drug Fixed Dose
- Ligand P-Gp Inhibition
- Pharmaceuticals Appendix
- Microwave-Induced in Situ Amorphization: a New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions
- The Central Mechanism Underlying Hypertension
- L:\0900\0900PHARMAPPX .Wpd
- Beneficial Effect of Efonidipine, an L- and T-Type Dual Calcium Channel Blocker, on Heart Rate and Blood Pressure in Patients
- The Effect of Antihypertensive Drugs on Chronic Kidney Disease: a Comprehensive Review
- A Comparative Study of the Diffusion of Antihypertensive and Antidepressant Medications in Germany and Japan
- Effects of Efonidipine, an L- and T-Type Calcium Channel Blocker, on the Renin-Angiotensin-Aldosterone System in Chronic Hemodi
- (12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
- Medications Associated with Geriatric Syndrome (MAGS) and Their Prevalence in Older Hospitalized Adults Discharged to Skilled Nursing Facilities
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances